[go: up one dir, main page]

MY109680A - 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions. - Google Patents

3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions.

Info

Publication number
MY109680A
MY109680A MYPI93002026A MYPI19932026A MY109680A MY 109680 A MY109680 A MY 109680A MY PI93002026 A MYPI93002026 A MY PI93002026A MY PI19932026 A MYPI19932026 A MY PI19932026A MY 109680 A MY109680 A MY 109680A
Authority
MY
Malaysia
Prior art keywords
oxindole
substituted
pharmaceutical compositions
formula
carboxamide
Prior art date
Application number
MYPI93002026A
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY109680A publication Critical patent/MY109680A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A PHARMACEUTICAL PREPARATION COMPRISING:(A)AT LEAST ONE TRIGLYCERIDE OR PROPYLENE GLYCOL DIESTER OF FRACTIONATED COCONUT OIL FATTY ACIDS; AND (B) AT LEAST ONE COMPOUND OF THE FORMULA(FORMULA 1)WHERE R1, R2 AND R3 ARE EACH INDEPENDENTLY HYDROGEN, FLUORO, BROMO, OR CHLORO, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.
MYPI93002026A 1992-10-07 1993-10-05 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions. MY109680A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07

Publications (1)

Publication Number Publication Date
MY109680A true MY109680A (en) 1997-04-30

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI93002026A MY109680A (en) 1992-10-07 1993-10-05 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions.

Country Status (21)

Country Link
EP (1) EP0662831A1 (en)
JP (1) JP2721042B2 (en)
KR (1) KR950703338A (en)
CN (1) CN1089138A (en)
AU (1) AU676200B2 (en)
BR (1) BR9307182A (en)
CA (1) CA2146448A1 (en)
CZ (1) CZ282702B6 (en)
EG (1) EG20289A (en)
FI (1) FI934387L (en)
HU (1) HUT68533A (en)
IL (1) IL107122A (en)
MX (1) MX9306222A (en)
MY (1) MY109680A (en)
NO (1) NO951350L (en)
NZ (1) NZ256164A (en)
PL (1) PL174170B1 (en)
RU (1) RU2119353C1 (en)
TW (1) TW438798B (en)
WO (1) WO1994007488A1 (en)
ZA (1) ZA937405B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (en) * 1993-08-26 1996-06-16 Pfizer PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
RU2109510C1 (en) * 1995-04-24 1998-04-27 Пфайзер Инк. Method of inhibition, tablet and capsule
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
JP5869764B2 (en) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 Capsule filling composition
CA3157812C (en) * 2019-10-25 2024-10-22 Cardiol Therapeutics Inc. Cannabidiol compositions for use in treating heart conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
WO1988005656A1 (en) * 1987-02-02 1988-08-11 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
ES2082196T3 (en) * 1990-03-02 1996-03-16 Shiseido Co Ltd OIL EMULSION COMPOSITION IN WATER CONTAINING A NON-STEROID ANTIGLOGISTIC ANALGESIC.
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength

Also Published As

Publication number Publication date
NZ256164A (en) 1997-03-24
ZA937405B (en) 1995-04-06
IL107122A (en) 1998-08-16
JPH07507809A (en) 1995-08-31
AU4839293A (en) 1994-04-26
EP0662831A1 (en) 1995-07-19
CZ282702B6 (en) 1997-09-17
FI934387A7 (en) 1994-04-08
PL174170B1 (en) 1998-06-30
KR950703338A (en) 1995-09-20
TW438798B (en) 2001-06-07
NO951350L (en) 1995-06-06
FI934387A0 (en) 1993-10-06
AU676200B2 (en) 1997-03-06
RU2119353C1 (en) 1998-09-27
FI934387L (en) 1994-04-08
WO1994007488A1 (en) 1994-04-14
CN1089138A (en) 1994-07-13
HU9302821D0 (en) 1993-12-28
NO951350D0 (en) 1995-04-06
JP2721042B2 (en) 1998-03-04
IL107122A0 (en) 1993-12-28
PL308307A1 (en) 1995-07-24
MX9306222A (en) 1994-04-29
CZ87895A3 (en) 1995-10-18
HUT68533A (en) 1995-04-27
EG20289A (en) 1998-07-30
BR9307182A (en) 1999-03-30
CA2146448A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
CA2182200A1 (en) Formulations for Factor IX
HUP9900925A2 (en) Sunscreen compositions
FI922542L (en) FATTY ACID COMPOSITIONS
NO911591D0 (en) PROCEDURE FOR THE PREPARATION OF SUCROSE-6 ESTER.
CA2129288A1 (en) Phosphonooxymethyl Esters of Taxane Derivatives
FI945411L (en) Cooling compositions
ITRM920560A0 (en) STORAGE UNIT FOR THE TEMPORARY STORAGE OF WAFER BLOCKS.
EG20279A (en) New derivatives of 3 arylpyrazoles used as fungicides
CA2154721A1 (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
CH692199A8 (en) PYRIDIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
WO1987000752A3 (en) Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters
NO163331C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 6,7-DISUBSTITUTED 1-CYCLEOPROPYL-1,4-DIHYDRO-4-OXO-1,8-NAFTYRIDINE-3-CARBOXYL ACIDS.
GR71716B (en)
CA2135346A1 (en) Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also presents antiinflamatory activity
MY109680A (en) 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions.
TW252979B (en)
IT8419141A0 (en) PROCEDURE FOR THE PREPARATION OF ALPHA-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER.
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
ES2111297T3 (en) NEW ESTERS OF 2-AMINO-7- (1,3-DIHIDROXI-2-PROPOXIMETIL) PURINE CARBOXYLIC ACIDS, THEIR PREPARATION AS WELL AS THEIR USE.
ZA897505B (en) Stable oxapenem-3-carboxylic acids and their use as beta-lactamase inhibitors
FI932396A0 (en) For the preparation of diphelic acid with 2,3-hydroxymethylcyclobutanol
ES2117003T3 (en) OLIGOPEPTIDICAL DERIVATIVES OF HIPOXANTINA GIVEN WITH IMMUNOMODULATING ACTIVITY, AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
HUT64339A (en) Process for producing pyrido/2,3-d/pyridazine-5/thi/on derivatives and herbvicidal compositions containing said compounds as active ingredients
IE792328L (en) Derivatives of dihydropyrrole and tetrahydropyridine.